Changes of tear film lipid layer thickness by 3% diquafosol ophthalmic solutions in patients with dry eye syndrome [PDF]
International Journal of Ophthalmology, 2019 AIM: To evaluate the quantitatively changes in lipid layer thickness (LLT) when 3% diquafosol eye drop is used for dry eye patients using the tear film interferometer.
Dong-Hyun Kang +7 more
doaj +3 more sources
Ophthalmic Solutions with a Broad Antiviral Action: Evaluation of Their Potential against Ocular Herpetic Infections [PDF]
Microorganisms, 2022 HSV-1 can be associated with severe and recurrent eye infections characterized by a strong inflammatory response that leads to blepharoconjunctivitis, epithelial and stromal keratitis, and retinal necrosis. The incidence of HSV-1 keratitis is 1.5 million
Carla Zannella +9 more
doaj +2 more sources
Inhibitory Effect of Ophthalmic Solutions against SARS-CoV-2: A Preventive Action to Block the Viral Transmission? [PDF]
Microorganisms, 2021 In 2020, a global pandemic was declared following the spread of SARS-CoV-2, the pathogen responsible for COVID-19. The risk of infection is high due to the ease of transmission, which can occur orally, through droplets, or via contact with contaminated ...
Francesco Petrillo +10 more
doaj +2 more sources
Broad-Spectrum Antimicrobial Activity of Oftasecur and Visuprime Ophthalmic Solutions [PDF]
Microorganisms, 2023 Due to the wide etiology of conjunctivitis, the expensive and time-consuming diagnosis requires new therapeutic strategies with broad-spectrum antimicrobial activity and nonselective mechanisms of action.
Federica Dell’Annunziata +8 more
doaj +2 more sources
In Vitro Evaluation of Combined Commercialized Ophthalmic Solutions Against Acanthamoeba Strains [PDF]
Pathogens, 2019 Acanthamoeba is a free-living amoebae genus which is present worldwide in natural and artificial environments. These amoebae are clinically important as causative agents of diseases in humans and other animals such as a fatal encephalitis or a sight ...
María Reyes-Batlle +14 more
doaj +2 more sources
Allergic Conjunctivitis Management: Update on Ophthalmic Solutions. [PDF]
Curr Allergy Asthma RepAbstract Purpose of Review The aim of this review, is to present an updated revision of topical management of SAC and PAC, based on the available scientific evidence and focused on the impact of ophthalmic solution formulations on eye surface.
Leonardi A +10 more
europepmc +4 more sources
Allergy to ophthalmic solutions [PDF]
Clin Transl Allergy, 2014 Lapeere H +3 more
europepmc +4 more sources
The Future Role of Physician Associates in Ophthalmology Services [PDF]
British and Irish Orthoptic JournalAs a response to increasing pressures on hospital eye services, the Royal College of Ophthalmologists (RCOphth) has started exploring the integration of physician associates (PAs) into ophthalmology as a means of expanding the ophthalmic workforce while ...
Yu Jeat Chong +2 more
doaj +2 more sources
In Vivo Pharmacokinetics of Bromfenac Ophthalmic Solution 0.075%, Bromfenac Ophthalmic Solution 0.07%, and Nepafenac/Amfenac Ophthalmic Suspension 0.3% in Rabbits [PDF]
Ophthalmology and Therapy, 2018 Little is known of the ocular distribution characteristics of currently branded non-steroidal anti-inflammatory drugs (NSAIDs) in the United States. This study was designed to predict the ocular bioavailability characteristics in humans using Dutch Belted rabbits as a surrogate.
John D. Sheppard +3 more
openalex +4 more sources
Ophthalmic regional blocks: management, challenges, and solutions
Local and Regional Anesthesia, 2015 Howard D Palte Department of Anesthesiology, Perioperative Medicine and Pain Management, Miller School of Medicine, University of Miami, Miami, FL, USA Abstract: In the past decade ophthalmic anesthesia has witnessed a major transformation.
Palte HD
doaj +5 more sources